Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru
Descripción del Articulo
Objective: To determine the frequency and clinical characteristics of children with drug-resistant epilepsy treated at a national hospital in Lima, Peru. Materials and methods: A prospective, case-series study was conducted on patients under 14 years of age with drug-resistant epilepsy, treated betw...
Autores: | , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2025 |
Institución: | Universidad Peruana Cayetano Heredia |
Repositorio: | Revistas - Universidad Peruana Cayetano Heredia |
Lenguaje: | español |
OAI Identifier: | oai:revistas.upch.edu.pe:article/6314 |
Enlace del recurso: | https://revistas.upch.edu.pe/index.php/RNP/article/view/6314 |
Nivel de acceso: | acceso abierto |
Materia: | drug resistant epilepsy antiepileptic drug ketogenic diet epilepsy/surgery pediatrics epilepsia resistente a los medicamentos fármacos antiepilépticos dieta cetogénica epilepsia/cirugía pediatría |
id |
REVUPCH_dbbf58ef11ede10ec3dfc8bebc434e9b |
---|---|
oai_identifier_str |
oai:revistas.upch.edu.pe:article/6314 |
network_acronym_str |
REVUPCH |
network_name_str |
Revistas - Universidad Peruana Cayetano Heredia |
repository_id_str |
|
dc.title.none.fl_str_mv |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru Epilepsia farmacorresistente en menores de 14 años: características clínicas y epidemiológicas en un hospital terciario de Lima, Perú |
title |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru |
spellingShingle |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru Espinoza-Quinteros, Ivan drug resistant epilepsy antiepileptic drug ketogenic diet epilepsy/surgery pediatrics epilepsia resistente a los medicamentos fármacos antiepilépticos dieta cetogénica epilepsia/cirugía pediatría |
title_short |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru |
title_full |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru |
title_fullStr |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru |
title_full_unstemmed |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru |
title_sort |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, Peru |
dc.creator.none.fl_str_mv |
Espinoza-Quinteros, Ivan Rivera-Burgos, Doris Liliana |
author |
Espinoza-Quinteros, Ivan |
author_facet |
Espinoza-Quinteros, Ivan Rivera-Burgos, Doris Liliana |
author_role |
author |
author2 |
Rivera-Burgos, Doris Liliana |
author2_role |
author |
dc.subject.none.fl_str_mv |
drug resistant epilepsy antiepileptic drug ketogenic diet epilepsy/surgery pediatrics epilepsia resistente a los medicamentos fármacos antiepilépticos dieta cetogénica epilepsia/cirugía pediatría |
topic |
drug resistant epilepsy antiepileptic drug ketogenic diet epilepsy/surgery pediatrics epilepsia resistente a los medicamentos fármacos antiepilépticos dieta cetogénica epilepsia/cirugía pediatría |
description |
Objective: To determine the frequency and clinical characteristics of children with drug-resistant epilepsy treated at a national hospital in Lima, Peru. Materials and methods: A prospective, case-series study was conducted on patients under 14 years of age with drug-resistant epilepsy, treated between October 2013 and March 2014. Drug resistance was defined as the persistence of seizures despite the use of at least two antiepileptic drug regimens at maximum tolerated doses. Data were collected through interviews with family members and a review of medical records. Results: Forty-six patients were enrolled, representing 26.0 % of children under 14 years of age treated for epilepsy. The mean age was 8.46 ± 3.55 years, with 42.6 % of patients being female. The median age at seizure onset was 10.3 months, and the average duration of epilepsy was 6.5 years. Most patients (66 %) had symptomatic or cryptogenic epilepsy, with brain malformations and postnatal infections being the most common causes (14.9 % each). A total of 17 % of the patients were diagnosed with idiopathic epilepsy. The most common types of epilepsy were focal epilepsy not otherwise specified (42.6 %) and generalized epilepsy not otherwise specified (17 %), followed by Lennox-Gastaut syndrome (14.9 %). Regarding antiepileptic treatment, 51.1 % were receiving dual therapy and 21.3 % were on triple therapy. Additionally, 89.4 % had learning disorders and 85.1 % had intellectual disability. Among children over 3 years old, 37.5 % were not attending school. 19.1 % were hospitalized at least once in the past year, with an average hospitalization duration of 20.1 days. Conclusions: Drug-resistant epilepsy has a significant impact on the health and quality of life of children, creating a substantial burden on the healthcare system. Improving access to specialized treatments and comprehensive patient management is essential. |
publishDate |
2025 |
dc.date.none.fl_str_mv |
2025-09-25 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://revistas.upch.edu.pe/index.php/RNP/article/view/6314 10.20453/rnp.v88i3.6314 |
url |
https://revistas.upch.edu.pe/index.php/RNP/article/view/6314 |
identifier_str_mv |
10.20453/rnp.v88i3.6314 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://revistas.upch.edu.pe/index.php/RNP/article/view/6314/6670 |
dc.rights.none.fl_str_mv |
Derechos de autor 2025 Ivan Espinoza-Quinteros, Doris Liliana Rivera-Burgos https://creativecommons.org/licenses/by-nc/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Derechos de autor 2025 Ivan Espinoza-Quinteros, Doris Liliana Rivera-Burgos https://creativecommons.org/licenses/by-nc/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidad Peruana Cayetano Heredia |
publisher.none.fl_str_mv |
Universidad Peruana Cayetano Heredia |
dc.source.none.fl_str_mv |
Revista de Neuro-Psiquiatria; Vol. 88 No. 3 (2025): Julio-septiembre; 234-243 Revista de Neuro-Psiquiatría; Vol. 88 Núm. 3 (2025): Julio-septiembre; 234-243 Revista de Neuro-Psiquiatria; v. 88 n. 3 (2025): Julio-septiembre; 234-243 1609-7394 0034-8597 10.20453/rnp.v88i3 reponame:Revistas - Universidad Peruana Cayetano Heredia instname:Universidad Peruana Cayetano Heredia instacron:UPCH |
instname_str |
Universidad Peruana Cayetano Heredia |
instacron_str |
UPCH |
institution |
UPCH |
reponame_str |
Revistas - Universidad Peruana Cayetano Heredia |
collection |
Revistas - Universidad Peruana Cayetano Heredia |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1844884514352922624 |
spelling |
Drug-resistant epilepsy in children under 14 years: clinical and epidemiological characteristics at a tertiary hospital in Lima, PeruEpilepsia farmacorresistente en menores de 14 años: características clínicas y epidemiológicas en un hospital terciario de Lima, PerúEspinoza-Quinteros, IvanRivera-Burgos, Doris Lilianadrug resistant epilepsyantiepileptic drugketogenic dietepilepsy/surgerypediatricsepilepsia resistente a los medicamentosfármacos antiepilépticosdieta cetogénicaepilepsia/cirugíapediatríaObjective: To determine the frequency and clinical characteristics of children with drug-resistant epilepsy treated at a national hospital in Lima, Peru. Materials and methods: A prospective, case-series study was conducted on patients under 14 years of age with drug-resistant epilepsy, treated between October 2013 and March 2014. Drug resistance was defined as the persistence of seizures despite the use of at least two antiepileptic drug regimens at maximum tolerated doses. Data were collected through interviews with family members and a review of medical records. Results: Forty-six patients were enrolled, representing 26.0 % of children under 14 years of age treated for epilepsy. The mean age was 8.46 ± 3.55 years, with 42.6 % of patients being female. The median age at seizure onset was 10.3 months, and the average duration of epilepsy was 6.5 years. Most patients (66 %) had symptomatic or cryptogenic epilepsy, with brain malformations and postnatal infections being the most common causes (14.9 % each). A total of 17 % of the patients were diagnosed with idiopathic epilepsy. The most common types of epilepsy were focal epilepsy not otherwise specified (42.6 %) and generalized epilepsy not otherwise specified (17 %), followed by Lennox-Gastaut syndrome (14.9 %). Regarding antiepileptic treatment, 51.1 % were receiving dual therapy and 21.3 % were on triple therapy. Additionally, 89.4 % had learning disorders and 85.1 % had intellectual disability. Among children over 3 years old, 37.5 % were not attending school. 19.1 % were hospitalized at least once in the past year, with an average hospitalization duration of 20.1 days. Conclusions: Drug-resistant epilepsy has a significant impact on the health and quality of life of children, creating a substantial burden on the healthcare system. Improving access to specialized treatments and comprehensive patient management is essential.Objetivo: Determinar la frecuencia y las características clínicas de los niños con epilepsia farmacorresistente (EFR) atendidos en un hospital nacional de Lima, Perú. Materiales y métodos: Estudio prospectivo, tipo serie de casos, que incluyó a pacientes menores de 14 años con EFR atendidos entre octubre de 2013 y marzo de 2014. Se definió farmacorresistencia como la persistencia de crisis a pesar del uso de al menos dos esquemas antiepilépticos adecuados a dosis máximas toleradas. Resultados: Participaron 47 pacientes, que representa al 26,0 % de los niños menores de 14 años atendidos por epilepsia en el nosocomio en mención. La edad promedio fue de 8,46 ± 3,55 años, con un 42,6 % de pacientes de sexo femenino. La mediana de edad de inicio de crisis fue de 10,3 meses, y el tiempo promedio de evolución de la epilepsia fue de 6,5 años. El 66 % presentó epilepsias sintomáticas o criptogénicas, siendo las malformaciones cerebrales y las infecciones postnatales las causas más comunes (14,9 % cada una). El 17 % presentaba epilepsias de causa idiopática. Predominaron las epilepsias focales no especificadas (42,6 %) y las generalizadas no especificadas (17 %), seguidas por el síndrome de Lennox-Gastaut (14,9 %). El 51,1 % recibía tratamiento antiepiléptico doble; y el 21,3 %, triple. El 89,4 % presentaba trastornos de aprendizaje; y el 85,1 %, discapacidad intelectual. Además, el 37,5 % de los niños mayores de 3 años no asistía a la escuela. El 19,1 % fue hospitalizado al menos una vez en el último año, con una duración promedio de 20,1 días. Conclusión: La EFR tiene un fuerte impacto en la salud y calidad de vida de los niños, y representa una carga significativa para el sistema de salud. Por tanto, es necesario mejorar el acceso a tratamientos especializados y fomentar el manejo integral de los pacientes.Universidad Peruana Cayetano Heredia2025-09-25info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistas.upch.edu.pe/index.php/RNP/article/view/631410.20453/rnp.v88i3.6314Revista de Neuro-Psiquiatria; Vol. 88 No. 3 (2025): Julio-septiembre; 234-243Revista de Neuro-Psiquiatría; Vol. 88 Núm. 3 (2025): Julio-septiembre; 234-243Revista de Neuro-Psiquiatria; v. 88 n. 3 (2025): Julio-septiembre; 234-2431609-73940034-859710.20453/rnp.v88i3reponame:Revistas - Universidad Peruana Cayetano Herediainstname:Universidad Peruana Cayetano Herediainstacron:UPCHspahttps://revistas.upch.edu.pe/index.php/RNP/article/view/6314/6670Derechos de autor 2025 Ivan Espinoza-Quinteros, Doris Liliana Rivera-Burgoshttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessoai:revistas.upch.edu.pe:article/63142025-09-25T21:32:59Z |
score |
13.914502 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).